Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
MagnetisMM-7: an open label, randomized, phase 3 study of elranatamab versus lenalidomide in patients with newly diagnosed multiple myeloma who are minimal residual disease-positive after transplant
- Authors
- Mateos, Maria-Victoria; Lee, Jae Hoon; Manier, Salomon; Vandendries, Erik; Benner, Rebecca; Yver, Anne
- Issue Date
- Aug-2022
- Publisher
- CIG MEDIA GROUP, LP
- Citation
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.22, pp.S45 - S45
- Journal Title
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Volume
- 22
- Start Page
- S45
- End Page
- S45
- ISSN
- 2152-2650
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Jae Hoon
- College of Medicine (Department of Medicine)